SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 114 filers reported holding SUTRO BIOPHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,492,100 | -19.8% | 430,000 | +7.5% | 0.01% | -38.5% |
Q2 2023 | $1,860,000 | +57.9% | 400,000 | +56.9% | 0.01% | +18.2% |
Q1 2023 | $1,178,100 | -64.9% | 255,000 | -38.6% | 0.01% | -81.4% |
Q4 2022 | $3,353,200 | +67.8% | 415,000 | +15.3% | 0.06% | +168.2% |
Q3 2022 | $1,998,000 | +0.9% | 360,000 | -5.3% | 0.02% | -4.3% |
Q2 2022 | $1,980,000 | -3.6% | 380,000 | +52.0% | 0.02% | -8.0% |
Q1 2022 | $2,055,000 | -39.9% | 250,000 | +8.7% | 0.02% | -32.4% |
Q4 2021 | $3,422,000 | -13.7% | 230,000 | +9.5% | 0.04% | -7.5% |
Q3 2021 | $3,967,000 | +1.6% | 210,000 | 0.0% | 0.04% | +25.0% |
Q2 2021 | $3,904,000 | -7.0% | 210,000 | +13.8% | 0.03% | -20.0% |
Q1 2021 | $4,199,000 | -32.0% | 184,501 | -35.1% | 0.04% | -46.7% |
Q4 2020 | $6,177,000 | +63.9% | 284,501 | -24.1% | 0.08% | +53.1% |
Q3 2020 | $3,769,000 | +27.1% | 375,000 | -1.8% | 0.05% | -7.5% |
Q2 2020 | $2,965,000 | +290.6% | 382,026 | +413.6% | 0.05% | +307.7% |
Q1 2020 | $759,000 | -13.7% | 74,385 | -6.9% | 0.01% | -7.1% |
Q4 2019 | $879,000 | +8.5% | 79,892 | -10.3% | 0.01% | +7.7% |
Q3 2019 | $810,000 | -28.8% | 89,081 | -10.9% | 0.01% | +8.3% |
Q2 2019 | $1,138,000 | -21.4% | 100,000 | -21.3% | 0.01% | -33.3% |
Q1 2019 | $1,447,000 | +57.6% | 127,005 | +24.7% | 0.02% | +125.0% |
Q4 2018 | $918,000 | -12.6% | 101,808 | +45.4% | 0.01% | -11.1% |
Q3 2018 | $1,050,000 | – | 70,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 1,824,542 | $34,466,000 | 16.86% |
Samsara BioCapital, LLC | 1,675,579 | $31,652,000 | 4.97% |
First Light Asset Management, LLC | 2,191,439 | $41,396,000 | 2.73% |
FRAZIER MANAGEMENT LLC | 1,468,663 | $27,743,000 | 2.22% |
AJU IB Investment Co., Ltd. | 175,000 | $3,306,000 | 2.13% |
Opaleye Management Inc. | 537,800 | $10,159,000 | 1.90% |
Parkman Healthcare Partners LLC | 163,389 | $3,086,000 | 0.78% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,233,695 | $42,194,000 | 0.71% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 139,331 | $2,629,000 | 0.63% |
BVF INC/IL | 826,825 | $15,619,000 | 0.61% |